What is Mounjaro?
Mounjaro is tirzepatide approved for type 2 diabetes, the first drug to activate both GIP and GLP-1 receptors. Approved in 2022, it set new benchmarks for both blood sugar control and weight loss in diabetes trials.
Like Ozempic before it, Mounjaro earned a massive off-label following for weight loss before its sibling Zepbound (same drug, weight-management label) arrived in late 2023.
For non-diabetics seeking weight loss, Zepbound is the on-label route and the one insurance will actually consider.
How it works
Tirzepatide mimics two incretin hormones at once. The GLP-1 action boosts insulin, suppresses appetite, and slows digestion; the GIP action improves fat metabolism and insulin sensitivity. Together they outperform single-mechanism GLP-1 drugs on nearly every diabetes metric.
In SURPASS-2, Mounjaro beat semaglutide 1 mg head-to-head on both A1C reduction and weight loss at every dose tested.
Dosing schedule
Mounjaro shares the tirzepatide titration ladder, 4 weeks minimum per step:
| Dose | When |
|---|---|
| 2.5 mg / week | Weeks 1–4, starter dose |
| 5 mg / week | First maintenance dose |
| 7.5–10 mg / week | Step up for more control |
| 12.5–15 mg / week | Maximum range |
Results in clinical trials
In SURPASS-2, tirzepatide reduced A1C by 2.0–2.3 points versus 1.9 for semaglutide, with weight loss of 17–25 lbs across doses versus 13 lbs for semaglutide. Over 90% of patients reached A1C below 7% at higher doses.
Side effects
Common
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Indigestion
Serious (rare)
- Pancreatitis
- Gallbladder disease
- Kidney injury
- Severe hypoglycemia with insulin or sulfonylureas
How much does Mounjaro cost?
Mounjaro pricing follows the branded GLP-1 pattern, high list, workable with coverage or savings programs:
| Route | Typical cost |
|---|---|
| List price | ~$1,070 / month |
| With insurance (diabetes diagnosis) | $25–$100 / month copay |
| Lilly savings card | As low as $25 / month (eligible commercial plans) |
| Off-label for weight loss | Usually full list price, not covered |
Prices vary by clinic, dose, and location, always confirm directly. See real local pricing on our clinic listings.
Frequently asked questions
Is Mounjaro better than Ozempic?
In the SURPASS-2 head-to-head trial, yes on the numbers, more A1C reduction and roughly double the weight loss versus semaglutide 1 mg. Ozempic still wins on cardiovascular outcome data history and sometimes on insurance formularies. Your coverage often makes the call.
Can I get Mounjaro for weight loss without diabetes?
Providers can prescribe off-label, but insurance will not cover it without a type 2 diabetes diagnosis. Zepbound is the identical drug with a weight-management approval. Ask about that instead; it also has cheaper cash-pay vial options through LillyDirect.
What is the difference between Mounjaro and Zepbound?
None chemically. Both are tirzepatide at the same doses. Mounjaro carries the diabetes approval, Zepbound the weight-management and sleep apnea approvals. The label determines insurance coverage, not the effect.
Related medications
Guides
Primary sources
- Mounjaro prescribing information, Eli Lilly
- Tirzepatide versus semaglutide in type 2 diabetes (SURPASS-2), New England Journal of Medicine
This page is for educational purposes only and is not medical advice. Mounjaro is a prescription medication. Talk to a licensed healthcare provider about whether it is right for you. GLPFinders is a directory service and does not prescribe, sell, or dispense medications.